|
WO2019224096A1
|
|
Heterocondensed pyridones compounds and their use as idh inhibitors
|
|
WO2019011715A1
|
|
Pyrazolo-quinazoline derivatives as choline kinase inhibitors
|
|
US2019225615A1
|
|
Purine and 3-deazapurine analogues as choline kinase inhibitors
|
|
US2019201406A1
|
|
N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors
|
|
MX2018014298A
|
|
New crystalline form of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-y l]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-be nzamide.
|
|
RU2726638C2
|
|
Asymmetric method for producing thieno-indole derivatives
|
|
KR20170082637A
|
|
6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors
|
|
EP3215513A1
|
|
Functionalized morpholinyl anthracycline derivatives
|
|
WO2015110467A1
|
|
Process for the preparation of substituted n-(5-benzenesulfonyl-1h-indazol-3-yl)-benzamides
|
|
WO2015044003A1
|
|
THIENO[2,3-e]INDOLE DERIVATIVES AS NEW ANTITUMOR AGENTS
|
|
CN105431436A
|
|
Pyrrolo[2,3-d]pyrimidine derivatives, process for their preparation and their use as kinase inhibitors
|
|
EP2991993A1
|
|
Morpholinyl anthracycline derivatives
|
|
US2015299192A1
|
|
Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors
|
|
US2015291613A1
|
|
Functionalized 9-bromo-camptothecin derivatives
|
|
WO2014064149A1
|
|
4-carboxamido-isoindolinone derivatives as selective parp-1 inhibitors
|
|
WO2014019908A2
|
|
Substituted pyrroles active as kinases inhibitors
|
|
CN104395308A
|
|
Process for the preparation of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
|
|
EP3587426A1
|
|
New alkylating agents
|
|
CN104203956A
|
|
Functionalized thieno-indole derivatives for the treatment of cancer
|
|
BR112014012031A2
|
|
3-phenyl isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
|
